{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:45:11Z","timestamp":1765485911401,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ghir.2015.06.002","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T04:49:01Z","timestamp":1433566141000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unaltered ratio of circulating levels of growth hormone\/GH isoforms in adults with Prader\u2013Willi syndrome after GHRH plus arginine administration"],"prefix":"10.1016","volume":"25","author":[{"given":"A.E.","family":"Rigamonti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Grugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Marazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sartorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2015.06.002_bb0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138920211795677877","article-title":"Prader\u2013Willi syndrome: obesity due to genomic imprinting","volume":"12","author":"Butler","year":"2011","journal-title":"Curr. Genomics"},{"issue":"2","key":"10.1016\/j.ghir.2015.06.002_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ajmg.a.36845","article-title":"A population-based profile of 160 Australians with Prader\u2013Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics","volume":"167","author":"Lionti","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.ghir.2015.06.002_bb0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jmg.38.11.792","article-title":"Population prevalence and estimated birth incidence and mortality rate for people with Prader\u2013Willi syndrome in one UK Health region","volume":"38","author":"Whittington","year":"2001","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ghir.2015.06.002_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader\u2013Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader\u2013Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.ghir.2015.06.002_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2003.11.003","article-title":"Prader\u2013Willi syndrome: advances in genetics, pathophysiology and treatment","volume":"15","author":"Goldstone","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2015.06.002_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","article-title":"French Reference Centre for PWS. Endocrine disorders in children with Prader\u2013Willi syndrome data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm. Res. Paediatr."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000323442","article-title":"The GH\/IGF-I axis and pituitary function and size in adults with Prader\u2013Willi syndrome","volume":"75","author":"van Nieuwpoort","year":"2011","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"10.1016\/j.ghir.2015.06.002_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2265.2006.02621.x","article-title":"Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader\u2013Willi syndrome","volume":"65","author":"Grugni","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"8","key":"10.1016\/j.ghir.2015.06.002_bb0050","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","article-title":"Metabolic profile and body composition in adults with Prader\u2013Willi syndrome and severe obesity","volume":"87","author":"H\u00f6ybye","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4\u20136","key":"10.1016\/j.ghir.2015.06.002_bb0055","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1758-8111.2011.00022.x","article-title":"A short clinical overview of Prader\u2013Willi syndrome","volume":"1","author":"McAllister","year":"2011","journal-title":"Clin. Obes."},{"issue":"3","key":"10.1016\/j.ghir.2015.06.002_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000284355","article-title":"GH\/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults","volume":"73","author":"Kreitschmann-Andermahr","year":"2010","journal-title":"Horm. Res. Paediatr."},{"issue":"10","key":"10.1016\/j.ghir.2015.06.002_bb0065","first-page":"937","article-title":"Growth hormone variants: a potential avenue for a better diagnostic characterization of growth hormone deficiency in children","volume":"35","author":"Rigamonti","year":"2012","journal-title":"J. Endocrinol. Investig."},{"issue":"9","key":"10.1016\/j.ghir.2015.06.002_bb0070","first-page":"2944","article-title":"Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure","volume":"82","author":"Boguszewski","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2015.06.002_bb0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/jcem.84.1.5402","article-title":"Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children","volume":"84","author":"Ishikawa","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2015.06.002_bb0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1530\/eje.0.1370246","article-title":"Circulating non-22kDa growth hormone isoforms in healthy children of normal stature: relation to height, body mass and pubertal development","volume":"137","author":"Boguszewski","year":"1997","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2015.06.002_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20yr)","volume":"29","author":"Cacciari","year":"2006","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.ghir.2015.06.002_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0095","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"2011 Growth Hormone in Prader\u2013Willi Syndrome Clinical Care Guidelines Workshop Participants. Growth-Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader\u2013Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2015.06.002_bb0100","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2012.188128","article-title":"Automated 22-kD growth hormone-specific assay without interference from Pegvisomant","volume":"58","author":"Manolopoulou","year":"2012","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EJE-07-0057","article-title":"Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration","volume":"156","author":"Keller","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2015.06.002_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2265.2011.04303.x","article-title":"Effects of recombinant human growth hormone therapy in adults with Prader\u2013Willi syndrome: a meta-analysis","volume":"77","author":"Sanchez-Ortiga","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2015.06.002_bb0115","first-page":"1615","article-title":"Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults","volume":"83","author":"Aimaretti","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2015.06.002_bb0120","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2015.06.002_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.ghir.2015.06.002_bb0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1152\/physrev.1999.79.2.511","article-title":"Neuroendocrine control of growth hormone secretion","volume":"79","author":"M\u00fcller","year":"1999","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.ghir.2015.06.002_bb0135","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1210\/jc.2012-2012","article-title":"Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans","volume":"97","author":"Tong","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2015.06.002_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0079-6123(06)53003-1","article-title":"The hypothalamus, hormones, and hunger: alterations in human obesity and illness","volume":"153","author":"Goldstone","year":"2006","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ghir.2015.06.002_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1651-2227.1997.tb18369.x","article-title":"Prader\u2013Willi syndrome and the hypothalamus","volume":"423","author":"Swaab","year":"1997","journal-title":"Acta Paediatr. Suppl."},{"issue":"1","key":"10.1016\/j.ghir.2015.06.002_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01403704","article-title":"MR of the pituitary in patients with Prader\u2013Willi syndrome: size determination and imaging findings","volume":"26","author":"Miller","year":"1996","journal-title":"Pediatr. Radiol."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00431-007-0555-3","article-title":"Pituitary height and neuroradiological alterations in patients with Prader\u2013Labhart\u2013Willi syndrome","volume":"167","author":"Iughetti","year":"2008","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ghir.2015.06.002_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ghir.2013.09.004","article-title":"The GHRH+arginine stimulated pituitary GH secretion in children and adults with Prader\u2013Willi syndrome shows age- and BMI-dependent and genotype-related differences","volume":"23","author":"Marostica","year":"2013","journal-title":"Growth Hormon. IGF Res."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637415300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:49:12Z","timestamp":1761086952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637415300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1096637415300046"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2015.06.002","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unaltered ratio of circulating levels of growth hormone\/GH isoforms in adults with Prader\u2013Willi syndrome after GHRH plus arginine administration","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2015.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}